BioNTech Correlations
| 0A3M Stock | USD 97.18 2.78 2.78% |
The current 90-days correlation between BioNTech SE and Cellnex Telecom SA is 0.02 (i.e., Significant diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BioNTech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BioNTech SE moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
BioNTech Correlation With Market
Average diversification
The correlation between BioNTech SE and DJI is 0.13 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding BioNTech SE and DJI in the same portfolio, assuming nothing else is changed.
BioNTech |
The ability to find closely correlated positions to BioNTech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BioNTech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BioNTech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BioNTech SE to buy it.
Moving against BioNTech Stock
| 0.8 | 0LQQ | Vodafone Group PLC | PairCorr |
| 0.67 | DSG | Dillistone Group | PairCorr |
| 0.64 | 0K8W | Derichebourg | PairCorr |
| 0.64 | 0F08 | Kongsberg Gruppen ASA | PairCorr |
| 0.52 | SLP | Sylvania Platinum | PairCorr |
| 0.49 | COD | Compagnie de Saint | PairCorr |
| 0.49 | TOWN | Town Centre Securities | PairCorr |
| 0.45 | JADE | Jade Road Investments | PairCorr |
| 0.45 | AEX | Aminex PLC | PairCorr |
| 0.37 | HSBK | Halyk Bank | PairCorr |
| 0.36 | 0ROM | Gestamp Automocion | PairCorr |
Related Correlations Analysis
| 0.41 | 0.55 | 0.31 | 0.45 | 0.29 | 0.57 | 0HW4 | ||
| 0.41 | 0.39 | 0.49 | 0.57 | 0.67 | 0.51 | 0R9C | ||
| 0.55 | 0.39 | 0.71 | 0.9 | 0.33 | 0.85 | LINV | ||
| 0.31 | 0.49 | 0.71 | 0.88 | 0.36 | 0.63 | 0QQZ | ||
| 0.45 | 0.57 | 0.9 | 0.88 | 0.46 | 0.81 | TBCG | ||
| 0.29 | 0.67 | 0.33 | 0.36 | 0.46 | 0.23 | PTEC | ||
| 0.57 | 0.51 | 0.85 | 0.63 | 0.81 | 0.23 | 0Q1S | ||
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Risk-Adjusted Indicators
There is a big difference between BioNTech Stock performing well and BioNTech Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze BioNTech's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 0HW4 | 1.32 | (0.07) | 0.00 | (0.24) | 0.00 | 2.68 | 11.78 | |||
| 0R9C | 1.30 | 0.04 | 0.04 | 0.02 | 1.88 | 2.27 | 13.74 | |||
| LINV | 0.93 | 0.11 | 0.09 | (1.92) | 0.96 | 2.22 | 8.07 | |||
| 0QQZ | 0.51 | 0.16 | 0.42 | (2.42) | 0.00 | 1.63 | 3.77 | |||
| TBCG | 1.63 | 0.61 | 0.42 | 0.81 | 1.11 | 4.33 | 12.62 | |||
| PTEC | 0.88 | 0.04 | 0.08 | 0.04 | 1.01 | 1.96 | 5.70 | |||
| 0Q1S | 1.23 | 0.03 | 0.06 | (0.16) | 2.03 | 2.11 | 15.84 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in BioNTech without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Efficient Frontier Now
Efficient FrontierPlot and analyze your portfolio and positions against risk-return landscape of the market. |
| All Next | Launch Module |
BioNTech Corporate Management
Elected by the shareholders, the BioNTech's board of directors comprises two types of representatives: BioNTech inside directors who are chosen from within the company, and outside directors, selected externally and held independent of BioNTech. The board's role is to monitor BioNTech's management team and ensure that shareholders' interests are well served. BioNTech's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, BioNTech's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Oliver Hennig | VP Operations | Profile | |
| Jens Holstein | CFO Board | Profile | |
| Sylke Maas | VP Strategy | Profile | |
| James Ryan | Chief Board | Profile | |
| Michael Boehler | MD Communications | Profile | |
| Ryan Richardson | MD Officer | Profile | |
| Sierk Poetting | COO MD | Profile |